Lobe Sciences Ltd.: Lobe Sciences Successfully Completes Proof-of-Concept of Proprietary Nasal Mist Device
Lobe Sciences Ltd.: Lobe Sciences Successfully Completes Proof-of-Concept of Proprietary Nasal Mist Device Vancouver, British Columbia--(Newsfile Corp. - February 18, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (" Lobe" or the " Company") announced today the completion and testing of the proof-of-concept prototype of its proprietary nasal mist device. As announced on December 3, 2020, the Company engaged VisionWorks Engineering of San Diego, CA to complete this first phase of development. Lobe's nasal mist device delivers "micro doses" of pharmaceutical agents such as a psilocyb...
Source: finanznachrichten.de